Byheart Acquires Additional Domestic Infant Formula Manufacturing Facility Tripling Its Supply Capacity And Continuing To Fortify Formula Production In The U.S.
Jan 25, 2023•over 2 years ago
Acquiring Company
ByHeart
Acquired Company
Infant Formula Manufacturing Facility
New YorkManufacturingHealth CareDescription
Today, ByHeart announces the acquisition of an additional manufacturing facility that will enable the next-generation baby nutrition company to scale production capacity of its breakthrough infant formula and increase domestic infant formula supply. Recognizing that the formula industry, which historically has been dominated by three players who control 90% of the market, was in need of change, ByHeart founders Ron Belldegrun and Mia Funt began working with DairiConcepts' FDA-registered facility in Allerton, Iowa, in 2018 to proactively build redundancy into their production ecosystem.
M&A Insights
Based on deal dataIntegration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed